Life forward - Boehringer Ingelheim unveils its evolved company brand

Ingelheim, Germany, 30/10/2023 | Boehringer Ingelheim, a leading research-driven biopharmaceutical company, on Monday presented a new corporate branding that is designed to inspire deeper connection with the company’s diverse customers, partners, and employees.

The evolved brand includes several striking changes including the introduction of a standout color palette and Boehringer Ingelheim’s first-ever brand claim “Life forward”. The claim builds on the foundation of the company purpose of 'transforming lives for generations’ and emphasizes how the company behaves in response to present-day and future challenges and the impact it intends to make.

As a key player in the industry, Boehringer Ingelheim pioneers breakthrough treatments in some of the most devastating disease areas. With the rise of non-communicable and infectious diseases for humans and animals, aging populations, and overwhelmed healthcare systems, the company addresses unmet medical needs for humans and animals in key areas such as cardio-renal-metabolic (CRM) diseases, inflammation, oncology and mental health.

“We have a responsibility to help address these challenges,” said Médard Schoenmaeckers, Boehringer Ingelheim’s Head of Corporate Affairs. “Momentum to introduce our evolved brand has never been better with our well-stocked innovation pipeline that will make significant differences for both humans and animals.”

Unwavering Optimism
The evolved brand introduces a modern, digital-first brand experience that leverages the company’s rich,
family-owned heritage, builds on its industry-leading approach to partnerships and amplifies its commitment to sustainability.

The core of the evolved corporate brand is: unwavering optimism. “In everything we do and say, we look
positively into the future because we know we can shape and influence it for the better and want to inspire others to join us,” adds Schoenmaeckers. “We have nearly 140 years of experience navigating the challenging dynamics of healthcare. And it is from that acquired resilience that we draw our confidence and the confidence that we can do better for the generations that come after us.”

Boehringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com.

Intended Audiences Notice
This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.